TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT06462729: LDGraft in Single Level Anterior Lumbar Interbody Fusion (ALIF)

Sponsor: Locate Bio Pty Ltd · Phase: PHASE1/PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 40 pts

Competing Trials Overlap

5 Active Trials

Excess Burn Exposure

$761,940

Rescue Site Savings

+$507,960

Unlock Full NCT06462729 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06462729 Rescue Dossier →